Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ampio, Anavex, Astrazeneca, Cel-Sci, Compass, Crinetics, Denali, Exelixis, Galera, Idorsia, Innovent, Ipsen, Italfarmaco, Kite, Lumos, Madrigal, Orphalan, Orphazyme, Partner, Polyphor, Poxel, Regeneron, Regulus, Sanofi, Terns, Transgene, Venatorx, Veru, Vir, Xbrane.